Evelo Biosciences, Inc. (EVLO)
Q3 2019 Earnings Conference Call
November 05, 2019, 08:30 ET
Company Participants
Jessica Cotrone - IR
Balkrishan Gill - President, CEO & Director
Duncan McHale - Chief Medical Officer
Mark Bodmer - Chief Scientific Officer & President, Research & Development
Conference Call Participants
Vikram Purohit - Morgan Stanley
Chris Shibutani - Cowen and Company
Na Sun - BMO Capital Markets
Christopher Howerton - Jefferies
Presentation
Operator
Good morning, and welcome to Evelo's conference call to discuss the interim clinical data from its Phase Ib trial of EDP1815. [Operator Instructions]. Please be